Scroll To Top
Search by Speciality

International Summit VI : Hypertrophic Cardiomyopathy – A Contemporary and Treatable Disease : Diagnosis, Heart Failure Management and Prevention of Sudden Death

Seaport Hotel Boston | Boston, USA
From 250 to 795 USD
Event Preview
This event
is Finished
Title: International Summit VI : Hypertrophic Cardiomyopathy - A Contemporary and Treatable Disease : Diagnosis, Heart Failure Management and Prevention of Sudden Death
Specialty: Cardiology
Dates: From Oct, 27, 2017 to Oct, 29, 2017
Location: Boston, USA
Type: Course
Registration Cost: From 250 to 795 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Boston, Usa.
General Info
Event Venue:

Seaport Hotel Boston

Boston, USA Visit the Venue to read more
Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

HCM Summit VI offers attendees an opportunity to learn the clinical, morphologic, and genetic spectrum of hypertrophic cardiomyopathy (HCM) from a renowned international faculty. We will explore a detailed contemporary view of HCM in which improved diagnostic techniques and management strategies have reduced disease mortality and vastly improved thousands of patients’ lives. 

Target Audience

Practicing cardiologists, internists, pediatricians, nurses and other healthcare professionals with an interest in HCM.

Residents, fellows, and medical students.

Clinicians and basic researchers directly involved with HCM

Learner Objectives / Outcomes

Choose contemporary management strategies for high-risk and other patient subgroups, including: surgical septal myectomy, alcohol septal ablation, and prevention of sudden death with implantable defibrillators.

Outline the causes of sudden death in competitive athletes and the profile of HCM in athlete populations.

Outline the pros and cons of different mas screening strategies for detecting HCM in general populations.

Interpret new advances in drug treatment, relief of LV outflow obstruction with novel operative or percutaneous techniques and the potential application of systems biology and personalized medicine to HCM. 

Activity Goals

Identify HCM’s clinical, morphologic, and genetic spectra.

Understand the natural history, clinical course, and overall disease burden of HCM.

Review contemporary management strategies including surgical septal myectomy, alcohol septal ablation, and sudden death prevention through implantable defibrillators.

Assess and determine appropriate advanced heart failure management and selection of patients for heart transplant.

Understand atrial fibrillation’s disease burden and contemporary management strategies.

Explore mechanisms responsible for adverse clinical events and natural history.

Learn the roles of advanced diagnostic modalities including magnetic resonance imaging (MRI) and novel echocardiographic techniques.

Understand the clinical significance and occurrence of left ventricular out ow obstruction (at rest and with provocation), and the natural history of patients without obstruction.

Learn competitive athlete sudden death causes and HCM profile in athlete populations.

Understand the pros and cons of mass screening strategies to detect HCM in general populations.

Discover key technologic developments in diagnosis, sudden death risk assessment, and myocardial fibrosis detection with contrast MRI.

Learn new advances in drug treatment, animal models, and LV out ow obstruction relief via novel operative or percutaneous techniques.

Explore the potential applications of systems biology, personalized medicine, and dedicated worldwide HCM Centers (including those in developing countries).

Registration Needs updating Register Now
General Info:

Registration confirmation, conference information, and survey will be sent via email. You will receive a reminder email including a map with directions one week prior to Summit VI. If you do not receive this confirmation, please contact us to verify your registration.



Registration Cost
Early Registration

Late Registration From: 2017-08-24 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


Seaport Hotel Boston

1 Seaport Lane

Boston, Massachusetts, United States Of America

Scientific Content Up to Date
Submission Info
Sponsors Exhibitors
General Info

Contact No.: +1 617-636-7000


Sponsors / Supporters


Philips Healthcare

MyoKardia, Inc.


Sanofi Genzyme

Medtronic, Inc.


The Boston Scientific Corporation

Ambry Genetics - Cardiology

Blueprint Genetics, Inc.

Invitae Corporation

Bristol-Myers Squibb

Organising Agency

Contact No.: +1 617-636-7000


Official Event Webpage
Event map
Revelant Events